Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
41 studies found for:    bryostatin
Show Display Options
Rank Status Study
1 Completed Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
Conditions: AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma
Interventions: Drug: bryostatin 1;   Drug: vincristine sulfate
2 Active, not recruiting A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin 1;   Other: Placebo
3 Completed Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Recurrent Melanoma;   Recurrent Renal Cell Cancer;   Stage IV Melanoma;   Stage IV Renal Cell Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bryostatin 1;   Drug: temsirolimus
4 Terminated
Has Results
Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin 1;   Drug: Placebo
5 Completed Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
Condition: HIV Infection
Interventions: Other: Placebo;   Drug: Bryostatin 1 (10ug/m2);   Drug: Bryostatin 1 (20ug/m2)
6 Completed
Has Results
Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: paclitaxel;   Drug: bryostatin 1
7 Unknown  Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
8 Completed Bryostatin and Vincristine in B-Cell Malignancies
Conditions: Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: bryostatin 1;   Drug: vincristine sulfate;   Other: laboratory biomarker analysis
9 Completed Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Nodal Marginal Zone B-cell Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Splenic Marginal Zone Lymphoma
Interventions: Drug: bryostatin 1;   Drug: vincristine sulfate;   Other: laboratory biomarker analysis
10 Completed Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer;   Stage III Ovarian Epithelial Cancer;   Stage IV Ovarian Epithelial Cancer
Interventions: Drug: bryostatin 1;   Drug: cisplatin;   Other: laboratory biomarker analysis
11 Completed A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: All-trans retinoic acid;   Drug: Bryostatin 1
12 Completed Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
Conditions: Recurrent Renal Cell Cancer;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Biological: aldesleukin;   Drug: bryostatin 1;   Other: laboratory biomarker analysis
13 Completed Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: bryostatin 1
14 Completed
Has Results
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
Conditions: Stage III Gastric Cancer;   Stage IV Gastric Cancer
Interventions: Drug: bryostatin 1;   Drug: cisplatin;   Other: laboratory biomarker analysis
15 Completed Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bryostatin 1;   Drug: gemcitabine hydrochloride
16 Completed Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: bryostatin 1;   Drug: chemotherapy
17 Completed Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
Condition: Kidney Cancer
Intervention: Drug: bryostatin 1
18 Completed Bryostatin 1 in Treating Patients With Stage IV Breast Cancer
Condition: Breast Cancer
Intervention: Drug: bryostatin 1
19 Completed Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: bryostatin 1
20 Completed Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: bryostatin 1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.